GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
24 hedge funds and large institutions have $9.55M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.13M | |
| 2 | +$390K | |
| 3 | +$59K | |
| 4 |
LF
Lee Financial
Dallas,
Texas
|
+$48K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
+$25.8K |
Top Sellers
| 1 | -$711K | |
| 2 | -$410K | |
| 3 | -$131K | |
| 4 |
Jane Street
New York
|
-$96.5K |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
-$80K |